Wendy Levine

Directeur/Membre du Conseil chez APYX MEDICAL CORPORATION Fortune : - $ au 30/04/2024

Profil

Wendy Levine is the founder of 21GRAMS, a company founded in 2018, where she holds the title of Group President & Head-Advertising Business.
She is currently the Director at Apyx Medical Corp.
since 2021.
In her former positions, Ms. Levine was the Senior Director-Marketing at Novartis Vaccines & Diagnostics, Inc. from 2007 to 2009, the Director-Client Services at GSW Advertising from 2015 to 2017, and the Executive Vice President & Managing Director at Mccann Health in 2014 to 2015.
She also held the position of Group Product Director-Specialty Pharmaceuticals at Johnson & Johnson.
Ms. Levine completed her undergraduate degree at the University of Pittsburgh and her graduate degree at Arcadia University.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
APYX MEDICAL CORPORATION -.--%	18/03/2024	0 ( -.--% )	- $	30/04/2024

Postes actifs de Wendy Levine

Sociétés	Poste	Début
APYX MEDICAL CORPORATION	Directeur/Membre du Conseil	25/08/2021
21GRAMS	Fondateur	01/01/2018

Anciens postes connus de Wendy Levine

Sociétés	Poste	Fin
GSW Advertising	Corporate Officer/Principal	01/01/2017
Mccann Health	Corporate Officer/Principal	01/01/2015
Novartis Vaccines & Diagnostics, Inc.	Sales & Marketing	01/01/2009
JOHNSON & JOHNSON	Corporate Officer/Principal	-

Formation de Wendy Levine

University of Pittsburgh	Undergraduate Degree
Arcadia University	Graduate Degree